chr3-37471115-C-A
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_002207.3(ITGA9):c.294C>A(p.Thr98=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00522 in 1,613,906 control chromosomes in the GnomAD database, including 274 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.025 ( 146 hom., cov: 31)
Exomes 𝑓: 0.0032 ( 128 hom. )
Consequence
ITGA9
NM_002207.3 synonymous
NM_002207.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.50
Genes affected
ITGA9 (HGNC:6145): (integrin subunit alpha 9) This gene encodes an alpha integrin. Integrins are heterodimeric integral membrane glycoproteins composed of an alpha chain and a beta chain that mediate cell-cell and cell-matrix adhesion. The protein encoded by this gene, when bound to the beta 1 chain, forms an integrin that is a receptor for VCAM1, cytotactin and osteopontin. Expression of this gene has been found to be upregulated in small cell lung cancers. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.3).
BP6
Variant 3-37471115-C-A is Benign according to our data. Variant chr3-37471115-C-A is described in ClinVar as [Benign]. Clinvar id is 702082.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-37471115-C-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-1.5 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0795 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ITGA9 | NM_002207.3 | c.294C>A | p.Thr98= | synonymous_variant | 2/28 | ENST00000264741.10 | NP_002198.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ITGA9 | ENST00000264741.10 | c.294C>A | p.Thr98= | synonymous_variant | 2/28 | 1 | NM_002207.3 | ENSP00000264741 | P1 | |
ITGA9 | ENST00000422441.5 | c.294C>A | p.Thr98= | synonymous_variant | 2/16 | 1 | ENSP00000397258 |
Frequencies
GnomAD3 genomes AF: 0.0248 AC: 3771AN: 151996Hom.: 145 Cov.: 31
GnomAD3 genomes
AF:
AC:
3771
AN:
151996
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00736 AC: 1852AN: 251470Hom.: 58 AF XY: 0.00578 AC XY: 785AN XY: 135914
GnomAD3 exomes
AF:
AC:
1852
AN:
251470
Hom.:
AF XY:
AC XY:
785
AN XY:
135914
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00318 AC: 4653AN: 1461792Hom.: 128 Cov.: 31 AF XY: 0.00286 AC XY: 2082AN XY: 727194
GnomAD4 exome
AF:
AC:
4653
AN:
1461792
Hom.:
Cov.:
31
AF XY:
AC XY:
2082
AN XY:
727194
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0248 AC: 3769AN: 152114Hom.: 146 Cov.: 31 AF XY: 0.0236 AC XY: 1757AN XY: 74350
GnomAD4 genome
AF:
AC:
3769
AN:
152114
Hom.:
Cov.:
31
AF XY:
AC XY:
1757
AN XY:
74350
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
15
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
ITGA9-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 18, 2020 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at